BMJ Best Practice
最后审核时间: 十月 2018
最近更新时间: 一月 2018

小结

定义

病史和查体

关键诊断因素

  • 存在危险因素
  • 高血压
  • BMI 增加
  • 腰围和臀围增加

其他诊断因素

  • 2 型糖尿病
  • 非酒精性脂肪性肝病
  • 心绞痛
  • 跛行

危险因素

  • 肥胖
  • 胰岛素抵抗
  • 体育活动不足
  • 高饱和脂肪饮食

诊断性检查

首要检查

  • 空腹血糖
  • 空腹甘油三酯
  • 空腹总胆固醇
  • 空腹高密度脂蛋白胆固醇(HDL-C)
全部具体信息

需要考虑的检查

  • 口服葡萄糖耐量试验
  • 血清尿素和肌酐
  • 转氨酶
  • 尿液分析
全部具体信息

治疗流程

疾病持续状态

贡献者

Endocrinologist

Department of Internal Medicine

Medical School

Aristotle University of Thessaloniki

Thessaloniki

Greece

利益冲突披露
PA declares that he has no competing interests.

Professor of Endocrinology

Department of Internal Medicine

Medical School

Aristotle University of Thessaloniki

Thessaloniki

Greece

利益冲突披露
FH declares that he has no competing interests.

同行评议专家 查看所有

Chief

Division of Endocrinology

Program Director

Endocrinology Fellowship

Division of Endocrinology, Diabetes and Metabolism

University of Florida College of Medicine

Jacksonville

FL

利益冲突披露
KW declares that he has no competing interests.

Professor

Center for Human Nutrition

The University of Texas Southwestern Medical Center

Dallas

TX

利益冲突披露
SG is an author of several references cited in this monograph. SG has consulted for several companies (Pfizer, AstraZeneca, Merck, Merck Schering Plough, Lilly, Abbott, Sanofi-Aventis, GlaxoSmithKline) that produce lipid-lowering drugs.

使用此内容应接受我们的免责声明